ACVIM small animal consensus statement on Lyme disease in dogs: diagnosis, treatment, and prevention.

The purpose of this report is to offer a consensus opinion of ACVIM diplomates on the diagnosis, treatment, and prevention of Borrelia burgdorferi infections in dogs (canine Lyme disease). Clinical syndromes known to commonly be associated with canine Lyme disease include polyarthritis and glomerulopathy. Serological test results can be used to document exposure to B. burgdorferi but not prove illness. Although serum enzyme-linked immunosorbent assay/indirect fluorescent antibody assay titers can stay positive for months to years after treatment, quantitative C6 peptide antibody paired tests need more study. Serological screening of healthy dogs is controversial because it can lead to overdiagnosis or overtreatment of normal dogs, most of which never develop Lyme disease. However, serological screening can provide seroprevalence and sentinel data and stimulate owner education about tick infections and control. Although it is unknown whether treatment of seropositive healthy dogs is beneficial, the consensus is that seropositive dogs should be evaluated for proteinuria and other coinfections and tick control prescribed. Tick control can include a product that repels or protects against tick attachment, thereby helping to prevent transmission of coinfections as well as Borrelia spp. Seropositive dogs with clinical abnormalities thought to arise from Lyme disease generally are treated with doxycycline (10 mg/kg q24h for 1 month). Proteinuric dogs might need longer treatment as well as medications and diets for protein-losing nephropathy. The ACVIM diplomates believe the use of Lyme vaccines still is controversial and most do not administer them. It is the consensus opinion that additional research is needed to study predictors of illness, "Lyme nephropathy," and coinfections in Lyme endemic areas.

[1]  R. Washabau,et al.  Suppurative, nonseptic polyarthropathy in dogs. , 2005, Journal of veterinary internal medicine.

[2]  Scott A. Brown,et al.  Assessment and management of proteinuria in dogs and cats: 2004 ACVIM Forum Consensus Statement (small animal). , 2005, Journal of veterinary internal medicine.

[3]  Richard S Hopkins,et al.  Summary of notifiable diseases--United States, 2003. , 2005, MMWR. Morbidity and mortality weekly report.

[4]  F. Trimarchi,et al.  Homologies between proteins of Borrelia burgdorferi and thyroid autoantigens. , 2004, Thyroid : official journal of the American Thyroid Association.

[5]  E. Breitschwerdt,et al.  The dog as a sentinel for human infection: prevalence of Borrelia burgdorferi C6 antibodies in dogs from southeastern and mid-Atlantic States. , 2004, Vector borne and zoonotic diseases.

[6]  M. Adelson,et al.  Comparison of Western Immunoblotting and the C6 Lyme Antibody Test for Laboratory Detection of Lyme Disease , 2004, Clinical Diagnostic Laboratory Immunology.

[7]  M. Adelson,et al.  Prevalence of Borrelia burgdorferi, Bartonella spp., Babesia microti, and Anaplasma phagocytophila in Ixodes scapularis Ticks Collected in Northern New Jersey , 2004, Journal of Clinical Microbiology.

[8]  S. Telford,et al.  Azotemia and mortality among Babesia microti-like infected dogs. , 2004, Journal of veterinary internal medicine.

[9]  B. Huber,et al.  An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  U. Munderloh,et al.  Experimental infection of dogs with Borrelia burgdorferi sensu stricto using Ixodes scapularis ticks artificially infected by capillary feeding , 2004, Medical Microbiology and Immunology.

[11]  S. Brorson,et al.  An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to tinidazole. , 2004, International microbiology : the official journal of the Spanish Society for Microbiology.

[12]  M. Cinco,et al.  Induction of cystic forms by different stress conditions in Borrelia burgdorferi , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[13]  R. Dornbush,et al.  Duration of Antibiotic Therapy for Early Lyme Disease , 2003, Annals of Internal Medicine.

[14]  A. Steere.  Duration of Antibiotic Therapy for Lyme Disease , 2003, Annals of Internal Medicine.

[15]  A. Steere,et al.  Serodiagnosis of Lyme Disease by Kinetic Enzyme-Linked Immunosorbent Assay Using Recombinant VlsE1 or Peptide Antigens of Borrelia burgdorferi Compared with 2-Tiered Testing Using Whole-Cell Lysates , 2003, The Journal of infectious diseases.

[16]  A. Steere,et al.  Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. , 2003, The Journal of infectious diseases.

[17]  E. Thacker,et al.  Report of the American Animal Hospital Association (AAHA) Canine Vaccine Task Force: executive summary and 2003 canine vaccine guidelines and recommendations. , 2003, Journal of the American Animal Hospital Association.

[18]  J. Reid,et al.  AVMA Council on Biologic and Therapeutic Agents' report on cat and dog vaccines. , 2002, Journal of the American Veterinary Medical Association.

[19]  D. Persing,et al.  Increased arthritis severity in mice coinfected with Borrelia burgdorferi and Babesia microti. , 2002, The Journal of infectious diseases.

[20]  M. Cinco,et al.  Cystic forms of Borrelia burgdorferi sensu lato: induction, development, and the role of RpoS. , 2002, Wiener klinische Wochenschrift.

[21]  B. Huber,et al.  Development of autoimmunity in Lyme arthritis. , 2002, Current opinion in rheumatology.

[22]  E. Breitschwerdt,et al.  Consensus statement on ehrlichial disease of small animals from the infectious disease study group of the ACVIM. American College of Veterinary Internal Medicine. , 2002, Journal of veterinary internal medicine.

[23]  S. Brorson,et al.  An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to hydroxychloroquine , 2002, International microbiology : the official journal of the Spanish Society for Microbiology.

[24]  L. Sigal.  Misconceptions about Lyme Disease: Confusions Hiding behind Ill-Chosen Terminology , 2002, Annals of Internal Medicine.

[25]  A. Frey,et al.  Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine. , 2001, Vaccine.

[26]  B. Soltys,et al.  H9724, a Monoclonal Antibody to Borrelia burgdorferi's Flagellin, Binds to Heat Shock Protein 60 (HSP60) Within Live Neuroblastoma Cells: A Potential Role for HSP60 in Peptide Hormone Signaling and in an Autoimmune Pathogenesis of the Neuropathy of Lyme Disease , 2001, Cellular and Molecular Neurobiology.

[27]  P. Mitchell,et al.  Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. , 2001, The Journal of infectious diseases.

[28]  E. Mordechai,et al.  Concurrent infection of the central nervous system by Borrelia burgdorferi and Bartonella henselae: evidence for a novel tick-borne disease complex. , 2001, Archives of neurology.

[29]  S. Levy,et al.  Efficacy of an amitraz-impregnated collar in preventing transmission of Borrelia burgdorferi by adult Ixodes scapularis to dogs. , 2001, Journal of the American Veterinary Medical Association.

[30]  C H Schmid,et al.  Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. , 2001, The New England journal of medicine.

[31]  R. Marcus,et al.  Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. , 2001, The New England journal of medicine.

[32]  D. Ma,et al.  Experimental induction of chronic borreliosis in adult dogs exposed to Borrelia burgdorferi-infected ticks and treated with dexamethasone. , 2001, American journal of veterinary research.

[33]  A. Steere,et al.  Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis. , 2001, Journal of autoimmunity.

[34]  E. Fikrig,et al.  Coinfection with Borrelia burgdorferi and the Agent of Human Granulocytic Ehrlichiosis Alters Murine Immune Responses, Pathogen Burden, and Severity of Lyme Arthritis , 2001, Infection and Immunity.

[35]  I. Gruntar,et al.  Conversion of Borrelia garinii cystic forms to motile spirochetes in vivo Note , 2001, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[36]  A. Steere,et al.  Molecular Mimicry in Lyme Arthritis Demonstrated at the Single Cell Level: LFA-1αL Is a Partial Agonist for Outer Surface Protein A-Reactive T Cells1 , 2001, The Journal of Immunology.

[37]  A. Siebers,et al.  DNA Vaccines Expressing a Fusion Product of Outer Surface Proteins A and C from Borrelia burgdorferi Induce Protective Antibodies Suitable for Prophylaxis but Not for Resolution of Lyme Disease , 2001, Infection and Immunity.

[38]  J. Braun,et al.  Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis , 2001, Annals of the rheumatic diseases.

[39]  R. Heffernan,et al.  Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs. , 2001, The Journal of infectious diseases.

[40]  R. H. Jacobson,et al.  Characterization of a Borrelia burgdorferi VlsE Invariable Region Useful in Canine Lyme Disease Serodiagnosis by Enzyme-Linked Immunosorbent Assay , 2000, Journal of Clinical Microbiology.

[41]  R. Schell,et al.  Detection of Borreliacidal Antibodies in Dogs after Challenge with Borrelia burgdorferi-Infected Ixodes scapularis Ticks , 2000, Journal of Clinical Microbiology.

[42]  P. Birner,et al.  Molecular mimicry in infectious encephalitis and neuritis: binding of antibodies against infectious agents on Western blots of human nervous tissue. , 2000, The Journal of infection.

[43]  E. Walker,et al.  Quantitative Approach for the Serodiagnosis of Canine Lyme Disease by the Immunoblot Procedure , 2000, Journal of Clinical Microbiology.

[44]  R. Straubinger.  PCR-Based Quantification of Borrelia burgdorferi Organisms in Canine Tissues over a 500-Day Postinfection Period , 2000, Journal of Clinical Microbiology.

[45]  R. H. Jacobson,et al.  Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: An experimental study. , 2000, The Journal of infectious diseases.

[46]  A. Spielman,et al.  Competence of American robins as reservoir hosts for Lyme disease spirochetes. , 2000, Emerging infectious diseases.

[47]  S. Bergström,et al.  Epidemiology: Reactivation of Borrelia infection in birds , 2000, Nature.

[48]  R. Schell,et al.  Occurrence of Severe Destructive Lyme Arthritis in Hamsters Vaccinated with Outer Surface Protein A and Challenged with Borrelia burgdorferi , 2000, Infection and Immunity.

[49]  M. Kramer,et al.  Resolution of experimental and tick‐borne Borrelia burgdorferiinfection in mice by passive, but not active immunization using recombinant OspC , 1999, European journal of immunology.

[50]  S. Brorson,et al.  An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[51]  H. Erb,et al.  Up-regulation of inducible nitric oxide synthase mRNA in dogs experimentally infected with Borrelia burgdorferi. , 1999, Veterinary immunology and immunopathology.

[52]  H. Erb,et al.  Clinical manifestations, pathogenesis, and effect of antibiotic treatment on Lyme borreliosis in dogs. , 1998, Wiener klinische Wochenschrift.

[53]  A. Steere,et al.  Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. , 1998, Science.

[54]  S. Brorson,et al.  A rapid method for generating cystic forms of Borrelia burgdorferi, and their reversal to mobile spirochetes , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[55]  S. Brorson,et al.  In vitro conversion ofBorrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium , 1998, Infection.

[56]  M. Philipp.  Studies on OspA: a source of new paradigms in Lyme disease research. , 1998, Trends in microbiology.

[57]  P. Oschmann,et al.  Detection and preliminary characterization of circulating immune complexes in patients with Lyme disease , 1997, Medical Microbiology and Immunology.

[58]  M. Klempner,et al.  Host—Pathogen Interactions in the Immunopathogenesis of Lyme Disease , 1997, Journal of Clinical Immunology.

[59]  S. Brorson,et al.  Transformation of cystic forms ofBorrelia burgdorferi to normal, mobile spirochetes , 1997, Infection.

[60]  H. Erb,et al.  Borrelia burgdorferi migrates into joint capsules and causes an up-regulation of interleukin-8 in synovial membranes of dogs experimentally infected with ticks , 1997, Infection and immunity.

[61]  D. Dambach,et al.  Morphologic, Immunohistochemical, and Ultrastructural Characterization of a Distinctive Renal Lesion in Dogs Putatively Associated with Borrelia burgdorferi Infection: 49 Cases (1987-1992) , 1997, Veterinary pathology.

[62]  R. Straubinger,et al.  Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment , 1997, Journal of clinical microbiology.

[63]  R. H. Jacobson,et al.  Lyme disease: laboratory diagnosis of infected and vaccinated symptomatic dogs. , 1996, Seminars in veterinary medicine and surgery.

[64]  Preac Mursic.  Formation and cultivation ofBorrelia burgdorferi spheroplast-L-form variants , 1996, Infection.

[65]  R. Schell,et al.  Macrophages exposed to Borrelia burgdorferi induce Lyme arthritis in hamsters , 1996, Infection and immunity.

[66]  G. Wanner,et al.  Formation and cultivation ofBorrelia burgdorferi spheroplast-L-form variants , 1996, Infection.

[67]  L. Durden,et al.  Ixodes (Ixodes) scapularis (Acari:Ixodidae): redescription of all active stages, distribution, hosts, geographical variation, and medical and veterinary importance. , 1996, Journal of medical entomology.

[68]  P. Mitchell,et al.  Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota , 1996, Journal of clinical microbiology.

[69]  R. H. Jacobson,et al.  Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi , 1995, Journal of clinical microbiology.

[70]  E. Aberer,et al.  Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi , 1995, Antimicrobial agents and chemotherapy.

[71]  R. Farina,et al.  Experimental infection of dogs with Borrelia burgdorferi. , 1994, Research in veterinary science.

[72]  R. Schell,et al.  Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi , 1994, Infection and immunity.

[73]  M. Mihatsch,et al.  Induction of experimental allergic arthritis with outer surface proteins of Borrelia burgdorferi. , 1994, Arthritis and rheumatism.

[74]  S. Malawista,et al.  Target imbalance: disparity of Borrelia burgdorferi genetic material in synovial fluid from Lyme arthritis patients. , 1994, The Journal of infectious diseases.

[75]  Levy Sa,et al.  Performance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas. , 1993 .

[76]  R. Todhunter,et al.  Experimental Lyme disease in dogs produces arthritis and persistent infection. , 1993, The Journal of infectious diseases.

[77]  D. A. Brandt,et al.  Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. , 1992, Arthritis and rheumatism.

[78]  Levy Sa,et al.  Relationship between development of antibodies to Borrelia burgdorferi in dogs and the subsequent development of limb/joint borreliosis. , 1992, Journal of the American Veterinary Medical Association.

[79]  A. Steere,et al.  The T-cell proliferative assay in the diagnosis of Lyme disease. , 1991, Annals of internal medicine.

[80]  S. Carter,et al.  Lyme disease in dogs , 1990, Veterinary Record.

[81]  J. Anderson,et al.  Persistence of antibodies to Borrelia burgdorferi in dogs of New York and Connecticut. , 1990, Journal of the American Veterinary Medical Association.

[82]  S. Badon,et al.  Survival of Borrelia burgdorferi in blood products , 1989, Transfusion.

[83]  Franks Jc.  Taking a hard look at Borrelia burgdorferi. , 1989 .

[84]  R. Walker,et al.  Heterogeneity in immunoblot patterns obtained by using four strains of Borrelia burgdorferi and sera from naturally exposed dogs , 1988, Journal of clinical microbiology.

[85]  S. Wright,et al.  Suspected Borreliosis in Cattle , 1988 .

[86]  Cooley Aj,et al.  Renal lesions associated with Borrelia burgdorferi infection in a dog. , 1988 .

[87]  J. Cullen,et al.  Clinical and serologic evaluations of induced Borrelia burgdorferi infection in dogs. , 1988, American journal of veterinary research.

[88]  J. Anderson,et al.  Clinical and serologic studies of canine borreliosis. , 1987, Journal of the American Veterinary Medical Association.

[89]  Burgess Ec.  Natural exposure of Wisconsin dogs to the Lyme disease spirochete (Borrelia burgdorferi). , 1986 .

[90]  A. Steere,et al.  Arthritis caused by Borrelia burgdorferi in dogs. , 1985, Journal of the American Veterinary Medical Association.

[91]  E. Bosler,et al.  Spirochete-associated arthritis (Lyme disease) in a dog. , 1984, Journal of the American Veterinary Medical Association.

[92]  J. P. Davis,et al.  Lyme disease: A tick-borne spirochetosis , 1983 .

[93]  K. K. Clark,et al.  Infection Rates in Dogs Vaccinated and Not Vaccinated With an OspA Borrelia burgdorferi Vaccine in a Lyme Disease-Endemic Area of Connecticut , 2005 .

[94]  T. Land,et al.  Use of imidacloprid-permethrin to prevent transmission of Anaplasma phagocytophilum from naturally infected Ixodes scapularis ticks to dogs. , 2004, Veterinary therapeutics : research in applied veterinary medicine.

[95]  E. Breitschwerdt,et al.  Transmission Times and Prevention of Tick-Borne Diseases in Dogs* , 2003 .

[96]  S. Levy,et al.  Utility of an in-office C6 ELISA test kit for determination of infection status of dogs naturally exposed to Borrelia burgdorferi. , 2002, Veterinary therapeutics : research in applied veterinary medicine.

[97]  E. Belongia.  Epidemiology and impact of coinfections acquired from Ixodes ticks. , 2002, Vector borne and zoonotic diseases.

[98]  S. Levy.  Use of a C6 ELISA test to evaluate the efficacy of a whole-cell bacterin for the prevention of naturally transmitted canine Borrelia burgdorferi infection. , 2002, Veterinary therapeutics : research in applied veterinary medicine.

[99]  D. Nelson,et al.  Serum-starvation-induced changes in protein synthesis and morphology of Borrelia burgdorferi. , 2000, Microbiology.

[100]  PhDb,et al.  Efficacy of a nonadjuvanted, outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi. , 2000, Veterinary therapeutics : research in applied veterinary medicine.

[101]  L. Sigal.  Lyme disease: a review of aspects of its immunology and immunopathogenesis. , 1997, Annual review of immunology.

[102]  Samuel L. Groseclose,et al.  Summary of Notifiable Diseases, United States. , 1997 .

[103]  K. Brandt,et al.  Effects of oral doxycycline administration on histomorphometry and dynamics of subchondral bone in a canine model of osteoarthritis. , 1996, The Journal of rheumatology.